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Summary
The efficiency of feedstuff utilization by
ruminal microorganisms and the cow’s
genetic ability to convert feed nutrients into
milk and milk components are major factors
that influence the profitability of a dairy
herd.  Monensin’s ability to modify the
movement of ions across biological mem-
branes leads to alterations in bacterial popu-
lations and subsequent changes in the pro-
portion of volatile fatty acids produced dur-
ing ruminal fermentation.  Manipulating
ruminal microbial populations with
ionophores has the potential to improve
performance by reducing ketosis, acidosis,
and bloat and increasing digestive efficiency.
Monensin improves fiber digestion by pre-
venting suboptimal ruminal pH, enhances
amino acid use by reducing the degradation
of dietary protein, and improves the energy
status of periparturient animals.  Monensin is
not approved for use in diets for lactating
dairy cows at this time, but its status is cur-
rently under review by the U.S. Food and
Drug Administration.  If approved, monensin
will provide another management tool to the
dairy industry.
(Key Words: Ionophore, Health, Efficiency.)
Introduction
The profitability of a dairy herd is a
function of the mail box price at the farm
level and the cost of production (overhead
and operational).  The herd manager can
influence the cost of production but has little
influence on the price received for milk.  An
analysis of individual items contributing to
the total cost of production reveals that feed
cost constitutes approximately 50% (range of
35-60%).  Thus, the efficient use of feed-
stuffs is a high priority issue for dairy pro-
ducers and researchers.
Feed efficiency is defined herein as
pounds of energy-corrected milk produced
per pound of feed consumed.  Energy-cor-
rected milk is used, because it accounts for
volume and energy content of milk (fat,
protein, and lactose).  Feed consumed is less
than feed offered, but feed wasted during
handling and feeding is a separate manage-
ment issue.  Milk and milk component yield
by the dairy cow is a function of her genetic
makeup and environment.  The diet fed to the
cow is a major aspect of the environmental
factors that influence her performance.  If we
assume that the cow is fed a properly formu-
lated diet and other environmental factors are
favorable, then her response to the diet de-
pends on the efficiency of feedstuff utiliza-
tion by ruminal microorganisms and the
cow’s genetic ability to convert feed nutri-
ents into milk
The purpose of this review is to explore
the implications of including monensin in
diets for lactating dairy cows, because it is
under review by the U.S. Food and Drug
Administration (FDA) as a potential feed
additive.
Monensin’s Mode of Action
Monensin and other ionophores have
been used as growth promotants in livestock
production systems for decades.  However,
monensin is known most notably for its
ability to alter the ruminal microbial popula-
tion, leading to increased proportions of the
gluconeogenic precursor propionate.  An
ionophore’s mode of action is to modify the
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movement of ions across biological mem-
branes.  Two major classes of bacteria exist
in the rumen: gram negative and gram posi-
tive.  Gram positive bacteria (cells possess-
ing a complex outer membrane) are resistant
to ionophores, whereas gram negative bacte-
ria are susceptible.  Bacterial cell membranes
consist of a lipid bilayer that regulates nutri-
ent exchange across the membrane.
Ionophores bind to gram-negative bacteria
and disrupt nutrient exchange that interferes
with proper cell function and can result in
cell death.  Alterations in bacterial popula-
tions lead to changes in the proportions of
volatile fatty acids (VFAs) produced during
ruminal fermentation. 
Effects on Animal Health Status
Management tools such as DHI records,
rBST, and a solid preventive herd health
program play a vital role in achieving higher
production efficiencies.  Monensin is yet
another management tool that could enhance
production efficiency and improve animal
health status.  As the dairy cow progresses
through various production phases (i.e., dry
period, early, mid-, and late-lactations) she
experiences a wide array of physiological
and dietary changes. These changes require
intense nutritional management to prevent
herd health problems and maximize perfor-
mance.  Manipulating the ruminal microbial
population with ionophores could improve
performance by reducing ketosis, acidosis,
and bloat and increasing digestive efficiency.
The transition from a nonlactating to a
lactating state increases nutrient demand at a
time when intake is less than optimal. The
cow responds by mobilizing tissue to support
lactation, which increases the risk of meta-
bolic disorders such as ketosis and fatty liver.
Monensin has the potential to reduce the
incidence of ketosis, because it increases the
proportion of propionate, a gluconeogenic
precursor, whereas total ruminal VFA con-
centrations either increase or remain un-
changed.  Increasing ruminal production of
propionate (contributes to glucose produc-
tion) reduces the need to synthesize glucose
from the amino acid pool in order to main-
tain adequate concentrations of blood glu-
cose.
Feeding diets containing an adequate
supply of nonstructural carbohydrates to
meet the lactational demand of the high-
producing dairy cow often predisposes the
animal to borderline acidosis.  The initial
onset of ruminal acidosis stems from an
overproduction of VFAs that lowers ruminal
pH (<5.5).  This affects the ruminal micro-
bial population, allowing lactic acid produc-
ers to outnumber lactic acid utilizers.
Monensin decreases the Streptococcus bovis
population, a major lactate producer, and
enhances the lactic acid utilizers.  The net
effect of monensin on ruminal acidosis yields
a more desirable ruminal pH (<5.8) for im-
proved fiber digestion.
Monensin also has demonstrated the
ability to reduce bloat.  Two major products
resulting from ruminal fermentation are acids
and gases.  The inability to eructate free gas
from the rumen results in bloat.  This inabil-
ity is caused by an accumulation of fluids,
solids, foam, and(or) slime that prevents the
free gas from reaching the cardia to be ex-
pelled via eructation.  Monensin reduces the
production of methane, and carbon dioxide,
the rate of rumen fill, and growth of micro-
bial species responsible for slime production.
A reduction in these bloat-provocative sub-
stances reduces the incidence of bloat within
the herd.  
Monensin also has a protein-sparing
effect and reduces ruminal ammonia produc-
tion. Its depressive effect on overall ruminal
cell numbers reduces activities of proteolytic
and deaminative enzymes, thus, increasing
the quantity of dietary protein escaping
ruminal degradation. This dietary protein
then would be available for postruminal
absorption.  Other researchers have found
that monensin reduces protozoan numbers in
vivo.  Because protozoa play a role in bacte-
rial protein recycling, ruminal ammonia
concentration is lower for cattle receiving
monensin.
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Feeding Recommendations
Monensin has not been cleared for use in
lactating dairy cow diets in the U.S.  How-
ever, data have been submitted to the U.S.
Food and Drug Administration for review.
Monensin has been cleared for use in other
countries, and the feeding recommendations
contained herein are based on their findings.
The impact of monensin on the digestion
of other dietary ingredients should be consid-
ered.  Incorporating monensin into a high-
fiber diet generally will result in increased
milk production because of increased energy
(in the form of glucose) available for milk
synthesis.  However, when monensin is
formulated into an energy-dense diet, dry
matter intake is reduced and milk production
unchanged, resulting in increased production
efficiency.  Monensin also improves protein
nutrition of the dairy cow, because more
amino acids are absorbed postruminally and
made available for milk protein synthesis or
gluconeogenesis rather than being degraded
by ruminal microbes.  This protein-sparing
effect is primarily due to a reduction in pro-
tein deamination activity in the rumen, mak-
ing more effective use of amino N.  There-
fore, diets designed for monensin inclusion
should contain sufficient high quality protein
to ensure the availability of essential amino
acids.
Because monensin enhances the energy
status of the cow, the greatest response to
feeding monensin is observed during the first
3 to 4 wk after calving and continues until
peak milk production.  During the immediate
prepartum period, the cow is in a negative
energy balance as fetal growth is maximized
and the mammary gland is preparing for the
subsequent lactation.  This energy imbalance
continues during early lactation.  Therefore,
the positive effect of monensin on perfor-
mance will continue until peak lactation
(usually 50 to 60 days postpartum).  Shortly
after this time, feed intake is sufficient to
meet the demand for milk synthesis.  Gener-
ally, no response in milk production has been
observed after peak milk production but
increases in body weight and body condition
resulted from the increased energy available
to the cow.
The amount of monensin to include in
the diet will be determined during the FDA
review process.  Doses used in research trials
have ranged from 10 ppm (equivalent to 10
mg/kg of feed dry matter) to 450 mg per
head per day. Research indicates that an in-
teraction may occur between dose and other
factors such as diet and stage of lactation. In
general, feeding monensin at different
amounts has decreased milk fat percentage
but had an insignificant effect on milk pro-
tein content.  Feeding monensin under condi-
tions known to decrease milk fat (low fiber,
high grain diets, and heat stress) has shown
the greatest negative impact on milk fat.
In conclusion, a recent review indicated
that monensin increased milk yield by ap-
proximately 2 lb per day.  Most importantly,
monensin could be useful in the prevention
of periparturient diseases, which are often-
times invisible costs impacting the efficiency
of production.  If it is approved for use in the
U.S., diet formulation strategies will vary
between farms based on production goals.  In
the end, monensin’s impact on the efficiency
of milk production should help improve the
dairy farm balance sheet.
